申请人:Lim Jongwon
公开号:US09023865B2
公开(公告)日:2015-05-05
Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1).
本发明揭示了式(1)的ERK抑制剂及其药学上可接受的盐。同时还揭示了使用式(1)的化合物治疗癌症的方法。